This notice provides information regarding WebTPA’s plans to assist our clients with their CAA Section 204 reporting obligations. We previously shared an overview of the reporting requirements, and we asked a few questions pertaining to your Plan’s submission of the various files. We have also been communicating with many of the PBM partners that our clients utilize to ensure that we are in sync with how they intend to submit data on behalf of our joint clients. Please note that this particular reporting exercise is largely prescription drug data, so the data that WebTPA will be able to provide in support of our clients, will be rather limited in scope.
Read Article

The U.S. Department of Health and Human Services (HHS) finalized an increase in the annual limit on cost-sharing for essential health benefits for non-grandfathered plans that apply to plan years beginning on or after January 1, 2023.
Read Article

The Consolidated Appropriations Act, 2021 (CAA) requires plans and issuers to submit information regarding the costs of prescription drugs and other health care services each year to the Center for Medicare & Medicaid Services (CMS). The rule generally applies to group health plans and health insurance issuers offering group or individual health insurance coverage. The term ‘‘group health plan’’ encompasses both self-funded and insured health plan, including employer-sponsored group health plans subject to ERISA, non-federal governmental plans (such as plans sponsored by states and local governments) subject to the Public Health Services (PHS) Act, and church plans subject to the Internal Revenue Code. Individual health insurance coverage includes student health insurance coverage. Plans consisting only of HIPAA excepted benefits do not have to comply.
Read Article

At the end of 2021, the IRS raised the fee that insurers and sponsors of self-insured health plans pay annually to fund the federal Patient-Centered Outcomes Research Institute (PCORI) trust fund.
Read Article